S

Stille AB
STO:STIL

Watchlist Manager
Stille AB
STO:STIL
Watchlist
Price: 203 SEK -1.93% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Stille AB?
Write Note

Stille AB
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stille AB
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
S
Stille AB
STO:STIL
Total Current Liabilities
kr181m
CAGR 3-Years
36%
CAGR 5-Years
43%
CAGR 10-Years
28%
Elekta AB (publ)
STO:EKTA B
Total Current Liabilities
kr14B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Total Current Liabilities
kr243.8m
CAGR 3-Years
3%
CAGR 5-Years
41%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Total Current Liabilities
kr129.4m
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
11%
Getinge AB
STO:GETI B
Total Current Liabilities
kr13.2B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Total Current Liabilities
kr4.4B
CAGR 3-Years
-6%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
No Stocks Found

Stille AB
Glance View

Market Cap
1.8B SEK
Industry
Health Care

Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.

STIL Intrinsic Value
286.89 SEK
Undervaluation 29%
Intrinsic Value
Price
S

See Also

What is Stille AB's Total Current Liabilities?
Total Current Liabilities
181m SEK

Based on the financial report for Sep 30, 2024, Stille AB's Total Current Liabilities amounts to 181m SEK.

What is Stille AB's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
28%

Over the last year, the Total Current Liabilities growth was 287%. The average annual Total Current Liabilities growth rates for Stille AB have been 36% over the past three years , 43% over the past five years , and 28% over the past ten years .

Back to Top